EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume -, Issue -, Pages ard-2022-223764
Publisher
BMJ
Online
2023-03-17
DOI
10.1136/ard-2022-223764
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis
- (2022) Joanna C Robson et al. ANNALS OF THE RHEUMATIC DISEASES
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis
- (2022) Peter C Grayson et al. ANNALS OF THE RHEUMATIC DISEASES
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis
- (2022) Ravi Suppiah et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
- (2022) George C Drosos et al. ANNALS OF THE RHEUMATIC DISEASES
- Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges
- (2022) Dorian Nezam et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis
- (2022) Jack Arnold et al. Frontiers in Immunology
- Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS
- (2022) Kate I Stevens et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline
- (2022) Linan Zeng et al. BMJ-British Medical Journal
- The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis
- (2022) Michael Walsh et al. BMJ-British Medical Journal
- POS0830 SYSTEMATIC LITERATURE REVIEW INFORMING THE 2022 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF ANCA-ASSOCIATED VASCULITIS: FOCUS ON TREATMENT STRATEGIES
- (2022) J. Schirmer et al. ANNALS OF THE RHEUMATIC DISEASES
- ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
- (2022) Sofia Ramiro et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
- (2022) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Heart Disease in Eosinophilic Granulomatosis with Polyangiitis (EGPA) Patients: a screening approach proposal
- (2021) Eloi Garcia-Vives et al. RHEUMATOLOGY
- Efficacy and Safety of Reslizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA)
- (2021) Laurie Manka et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs
- (2021) Johannes WJ Bijlsma ANNALS OF THE RHEUMATIC DISEASES
- Avacopan for the Treatment of ANCA-Associated Vasculitis
- (2021) David R.W. Jayne et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases
- (2021) Robert Spiera et al. ANNALS OF THE RHEUMATIC DISEASES
- Correction to: French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
- (2021) Benjamin Terrier et al. Orphanet Journal of Rare Diseases
- The role of trimethoprim/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis
- (2021) Sara Monti et al. RHEUMATOLOGY
- SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
- (2021) Daniel Mrak et al. ANNALS OF THE RHEUMATIC DISEASES
- Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis.
- (2021) Kavita Gulati et al. KIDNEY INTERNATIONAL
- Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (Churg–Strauss)
- (2021) Silvia Sartorelli et al. RHEUMATOLOGY
- A real-world assessment of mycophenolate mofetil for remission induction in eosinophilic granulomatosis with polyangiitis
- (2021) Mariana Philobos et al. RHEUMATOLOGY INTERNATIONAL
- Comparative effectiveness of trimethoprim-sulfamethoxazole versus atovaquone for the prophylaxis of pneumocystis pneumonia in patients with connective tissue diseases receiving prolonged high-dose glucocorticoids
- (2021) Sadao Jinno et al. RHEUMATOLOGY INTERNATIONAL
- Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis
- (2021) M Antonelou et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- (2021) Sharon A. Chung et al. Arthritis & Rheumatology
- Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study
- (2021) Alessandra Bettiol et al. Arthritis & Rheumatology
- 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
- (2021) Alessia Alunno et al. ANNALS OF THE RHEUMATIC DISEASES
- The COVID-19 pandemic and ANCA-associated vasculitis – reports from the EUVAS meeting and EUVAS education forum
- (2021) Andreas Kronbichler et al. AUTOIMMUNITY REVIEWS
- Disease Activity and Adverse Events in Patients with ANCA-Associated Vasculitides Undergoing Long-Term Dialysis
- (2021) Maëlis Kauffmann et al. Clinical Journal of the American Society of Nephrology
- Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
- (2021) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- The impact of a structured one–day seminar on disease–specific knowledge, lifestyle habits and disease impairment in ANCA–associated vasculitis. Results of a randomized, controlled study
- (2021) N Garbe et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Predictors of fatal and non-fatal cardiovascular events in ANCA-associated vasculitis: Data from the Toronto CanVasc cohort
- (2020) Eline Houben et al. JOINT BONE SPINE
- Initial high-dose corticosteroids and renal impairment are risk factors for early severe infections in elderly patients with antineutrophil cytoplasmic autoantibody-associated vasculitis
- (2020) Daisuke Waki et al. MEDICINE
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
- (2020) Michael Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- The nose is an organ too
- (2020) Chetan Mukhtyar et al. RHEUMATOLOGY
- Usefulness of vasculitis biomarkers in the era of the personalized medicine
- (2020) Elena Csernok et al. AUTOIMMUNITY REVIEWS
- Clinical Characteristics of an Internet-Based Cohort of Patients with a Self-Reported Diagnosis of Granulomatosis with Polyangiitis or Microscopic Polyangiitis: Observational Study (Preprint)
- (2020) Jason Michael Springer et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis
- (2020) Sergey Moiseev et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- (2020) Pierre Charles et al. ANNALS OF INTERNAL MEDICINE
- Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis
- (2020) Emma E. van Daalen et al. Clinical Journal of the American Society of Nephrology
- Experience with similar biologic rituximab in 77 patients of granulomatosis with polyangiitis—a real-life experience
- (2020) Sakshi Mittal et al. CLINICAL RHEUMATOLOGY
- Proteinase-3-anti-neutrophil cytoplasmic antibodies (PR3-ANCAs) predict relapses in ANCA–associated vasculitis patients after rituximab
- (2020) Laura S van Dam et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- LB004A RANDOMIZED, CONTROLLED TRIAL OF RITUXIMAB VERSUS AZATHIOPRINE AFTER INDUCTION OF REMISSION WITH RITUXIMAB FOR PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND RELAPSING DISEASE
- (2020) Rona Smith et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis
- (2020) Michael D. George et al. ANNALS OF INTERNAL MEDICINE
- 2020 international consensus on ANCA testing beyond systemic vasculitis
- (2020) Sergey Moiseev et al. AUTOIMMUNITY REVIEWS
- CanVasc consensus recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitis: 2020 update
- (2020) Arielle Mendel et al. JOURNAL OF RHEUMATOLOGY
- Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with Severe Renal Disease
- (2020) Marta Casal Moura et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis with Polyangiitis: data from a European Collaborative Study
- (2020) Alice Canzian et al. Arthritis & Rheumatology
- Benralizumab as a steroid-sparing treatment option in eosinophilic granulomatosis with polyangiitis
- (2020) Vamsi P. Guntur et al. Journal of Allergy and Clinical Immunology-In Practice
- Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
- (2020) Matthias Papo et al. RHEUMATOLOGY
- Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
- (2019) Rachel B Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in ANCA-Associated Vasculitis: A Randomized Controlled Study
- (2019) David Jayne et al. Arthritis & Rheumatology
- Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study
- (2019) Dimitrios Chanouzas et al. BMC Nephrology
- Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification
- (2019) Samuel Deshayes et al. RHEUMATOLOGY
- Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis
- (2019) Mark E. McClure et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: Systematic literature review
- (2019) Sonali Wijetilleka et al. AUTOIMMUNITY REVIEWS
- Chest High-Resolution CT Findings of Microscopic Polyangiitis: A Japanese First Nationwide Prospective Cohort Study
- (2019) Aika Suzuki et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial
- (2019) Xavier Puéchal et al. RHEUMATOLOGY
- Comparison of the birmingham vasculitis activity score and the five factors score to assess survival in anca‐associated vasculitis
- (2019) Roser Solans‐Laqué et al. ARTHRITIS CARE & RESEARCH
- 2018 Update of the EULAR recommendations for the management of large vessel vasculitis
- (2019) Bernhard Hellmich et al. ANNALS OF THE RHEUMATIC DISEASES
- Oral candidiasis is a significant predictor of subsequent severe infections during immunosuppressive therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis
- (2019) Makoto Yamaguchi et al. BMC INFECTIOUS DISEASES
- Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- (2019) Janneke Tuin et al. Clinical Journal of the American Society of Nephrology
- Risk of opportunistic infections in patients with antineutrophil cytoplasmic antibody‐associated vasculitis, using a Japanese health insurance database
- (2019) Ryoko Sakai et al. International Journal of Rheumatic Diseases
- Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis
- (2019) Kaitlin A Quinn et al. RHEUMATOLOGY
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- (2019) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status
- (2019) Paul A Lyons et al. Nature Communications
- Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines
- (2019) Joanna Tieu et al. RHEUMATOLOGY
- Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question
- (2018) Kevin L Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis
- (2018) Andreas Kronbichler et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis
- (2018) Stephen P McAdoo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Accuracy of Magnetic Resonance Imaging for Grading of Subglottic Stenosis in Patients With Granulomatosis With Polyangiitis: Correlation With Pulmonary Function Tests and Laryngoscopy
- (2018) Frank O. Henes et al. ARTHRITIS CARE & RESEARCH
- Association between reappearance of myeloperoxidase-antineutrophil cytoplasmic antibody and relapse in antineutrophil cytoplasmic antibody-associated vasculitis: Subgroup analysis of nationwide prospective cohort studies
- (2018) Haruki Watanabe et al. Arthritis & Rheumatology
- Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides
- (2018) Benjamin Terrier et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluation of clinical benefit from treatment with mepolizumab for eosinophilic granulomatosis with polyangiitis
- (2018) Jonathan Steinfeld et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Development and validation of a renal risk score in ANCA-associated glomerulonephritis
- (2018) Silke R. Brix et al. KIDNEY INTERNATIONAL
- Estimating the epidemiology of anti-neutrophil cytoplasm antibody-associated renal vasculitis and the role of histologic chronicity in predicting renal outcomes
- (2018) Andreas Kronbichler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases
- (2018) Sonali Wijetilleka et al. RHEUMATOLOGY
- Effect of disease activity at three and six months on long-term outcomes in ANCA associated vasculitis
- (2018) Seerapani Gopaluni et al. Arthritis & Rheumatology
- Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis: The Influence of ANCA Subtype
- (2017) Aladdin J. Mohammad et al. JOURNAL OF RHEUMATOLOGY
- Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients
- (2017) Stephen P. McAdoo et al. KIDNEY INTERNATIONAL
- Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides
- (2017) Roser Solans-Laqué et al. MEDICINE
- Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis
- (2017) Xavier Bossuyt et al. Nature Reviews Rheumatology
- Vasculitis—when can biopsy be avoided?
- (2017) David Jayne NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
- (2017) Michael E. Wechsler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data
- (2017) Anoek A E de Joode et al. RHEUMATOLOGY
- Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
- (2017) Joanna C. Robson et al. RHEUMATOLOGY INTERNATIONAL
- Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors
- (2017) Xavier Puéchal et al. Arthritis & Rheumatology
- Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial
- (2017) Federica Maritati et al. PLoS One
- EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures
- (2016) W F Lems et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis
- (2016) Emma E van Daalen et al. ANNALS OF THE RHEUMATIC DISEASES
- The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
- (2016) Carina Götestam Skorpen et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
- (2016) M Yates et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
- (2016) L Andreoli et al. ANNALS OF THE RHEUMATIC DISEASES
- Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays
- (2016) Jan Damoiseaux et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
- (2016) R Agca et al. ANNALS OF THE RHEUMATIC DISEASES
- Prognostic Value of Histologic Classification of ANCA-Associated Glomerulonephritis
- (2016) R. Bjorneklett et al. Clinical Journal of the American Society of Nephrology
- Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate
- (2016) Courtney S. Watts et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial
- (2016) Jan-Stephan F. Sanders et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibody-Positive Interstitial Pneumonia Associated with Granulomatosis with Polyangiitis Diagnosed by Surgical Lung Biopsy
- (2016) Haruka Chino et al. RESPIRATION
- Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes
- (2016) Rodrigo Cartin-Ceba et al. Arthritis & Rheumatology
- Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
- (2015) Rachel B Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of cardiac magnetic resonance imaging on eosinophilic granulomatosis with polyangiitis outcomes: A long-term retrospective study on 42 patients
- (2015) Bertrand Dunogué et al. AUTOIMMUNITY REVIEWS
- Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease
- (2015) Darren M. Roberts et al. JOURNAL OF AUTOIMMUNITY
- Rituximab for treatment of severe renal disease in ANCA associated vasculitis
- (2015) Duvuru Geetha et al. JOURNAL OF NEPHROLOGY
- Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome
- (2015) A. Knight et al. JOURNAL OF RHEUMATOLOGY
- Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort
- (2015) Jan H. Schirmer et al. RHEUMATOLOGY
- Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experience
- (2015) Benjamin Terrier et al. RHEUMATOLOGY
- Outcomes of Nonsevere Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated With Glucocorticoids
- (2015) E. M. Miloslavsky et al. Arthritis & Rheumatology
- Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies
- (2015) Weifeng Shang et al. PLoS One
- Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)
- (2014) A J Mohammad et al. ANNALS OF THE RHEUMATIC DISEASES
- 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
- (2014) Désirée van der Heijde et al. ANNALS OF THE RHEUMATIC DISEASES
- Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors
- (2014) Maxime Samson et al. AUTOIMMUNITY REVIEWS
- Granulomatosis With Polyangiitis (Wegener’s)
- (2014) Jason Springer et al. MEDICINE
- Repeat protocol renal biopsy in ANCA-associated renal vasculitis
- (2014) Z. Hruskova et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
- (2014) Loïc Guillevin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and Imaging Features Predictive of Orbital Granulomatosis with Polyangiitis and the Risk of Systemic Involvement
- (2014) Lee Teak Tan et al. OPHTHALMOLOGY
- Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis
- (2014) Federico Alberici et al. RHEUMATOLOGY
- Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis
- (2014) Mikkel Faurschou et al. RHEUMATOLOGY
- Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis
- (2013) Kirsten de Groot ANNALS OF INTERNAL MEDICINE
- Integration of 2-deoxy-2-[18F] fluoro-d-glucose PET/CT into clinical management of patients with Wegener’s granulomatosis
- (2013) Ozlem Ozmen et al. ANNALS OF NUCLEAR MEDICINE
- EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
- (2013) N Duru et al. ANNALS OF THE RHEUMATIC DISEASES
- Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials
- (2013) Joanna Robson et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) enrolled in two prospective trials
- (2013) Maxime Samson et al. JOURNAL OF AUTOIMMUNITY
- Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear
- (2013) Michael Walsh et al. KIDNEY INTERNATIONAL
- Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
- (2013) Ulrich Specks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial
- (2013) Michael Walsh et al. Trials
- Evaluation of Wegener’s granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography
- (2012) Kimiteru Ito et al. ANNALS OF NUCLEAR MEDICINE
- A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients
- (2012) Frank Moosig et al. ANNALS OF THE RHEUMATIC DISEASES
- Brief Report: Long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis
- (2012) Mikkel Faurschou et al. ARTHRITIS AND RHEUMATISM
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
- (2012) J. C. Jennette et al. ARTHRITIS AND RHEUMATISM
- Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort
- (2012) Cloé Comarmond et al. ARTHRITIS AND RHEUMATISM
- Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis
- (2012) Sophia Lionaki et al. ARTHRITIS AND RHEUMATISM
- Magnetic resonance imaging in patients with granulomatosis with polyangiitis (Wegener’s) and subglottic stenosis
- (2012) Thorsten Klink et al. MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE
- Genetically Distinct Subsets within ANCA-Associated Vasculitis
- (2012) Paul A. Lyons et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides
- (2012) Nils Venhoff et al. PLoS One
- Effects of Mycophenolate Mofetil Combined with Corticosteroids for Induction Therapy of Microscopic Polyangiitis
- (2011) Fei Han et al. AMERICAN JOURNAL OF NEPHROLOGY
- Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
- (2011) Lorraine Harper et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis
- (2011) Michael Walsh et al. ARTHRITIS AND RHEUMATISM
- The Five-Factor Score Revisited
- (2011) Loïc Guillevin et al. MEDICINE
- Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis
- (2011) N. Mansfield et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)
- (2011) Megan E. B. Clowse et al. ARTHRITIS CARE & RESEARCH
- A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis
- (2011) Ravi Suppiah et al. ARTHRITIS CARE & RESEARCH
- Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis
- (2010) Michael Walsh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?
- (2010) J. U. Holle et al. ANNALS OF THE RHEUMATIC DISEASES
- Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice
- (2010) M. C. van der Goes et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term patient survival in ANCA-associated vasculitis
- (2010) O. Flossmann et al. ANNALS OF THE RHEUMATIC DISEASES
- Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades
- (2010) Julia U. Holle et al. ARTHRITIS AND RHEUMATISM
- Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- (2010) Thomas F. Hiemstra et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- AGREE II: Advancing guideline development, reporting and evaluation in health care
- (2010) Melissa C. Brouwers et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Histopathologic Classification of ANCA-Associated Glomerulonephritis
- (2010) A. E. Berden et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener's granulomatosis--a clinical randomized controlled trial
- (2010) W. M. Szpirt et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: A meta-analysis
- (2010) Michael Walsh et al. ARTHRITIS CARE & RESEARCH
- Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis
- (2009) M. A. Little et al. ANNALS OF THE RHEUMATIC DISEASES
- The clinical course of ANCA small-vessel vasculitis on chronic dialysis
- (2009) Sofia Lionaki et al. KIDNEY INTERNATIONAL
- Modification and validation of the Birmingham Vasculitis Activity Score (version 3)
- (2008) C Mukhtyar et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of primary small and medium vessel vasculitis
- (2008) C Mukhtyar et al. ANNALS OF THE RHEUMATIC DISEASES
- Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis
- (2008) Christian Pagnoux et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis
- (2008) Y. Gao et al. RHEUMATOLOGY
- Longitudinale Effekte des strukturierten Patientenschulungsprogramms für Vaskulitispatienten
- (2008) K. Herlyn et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started